| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.093 | 0.8 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |